Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Sodium Butyrate: SANE MD Viscera-3® Leads 2024 Gut Health Revolution, Now Available on Amazon
-
Early Warning Report Issued Pursuant to National Instrument 62-103 in Respect of the Acquisition of Shares of Nexus Uranium Corp. (NEXU)
-
Myriad Uranium Announces Additional Historical Grade Intervals and New Insights from the Copper Mountain Uranium Project, Wyoming, USA
-
Elektros Launches First Lithium Shipments from Sierra Leone Mining Site
-
Sphere 3D Corp. Provides August 2024 Update
-
FTI Consulting Adds EY Global M&A Leader to Transactions Practice
-
Class 1 Nickel Provides Update on Dundonald South Nickel Sulphide Deposit and the Alexo-Dundonald Advanced Nickel Sulphide Project, Timmins, Canada
-
FTI Consulting Adds EY Global M&A Leader to Transactions Practice
-
Biohaven Achieves Positive Topline Results in Pivotal Study of Troriluzole in Spinocerebellar Ataxia (SCA)
-
NEVADA KING INTERSECTS 53.8M OF 4.10 G/T AU, 35.1M OF 3.59 G/T AU AND 24.4M OF 1.76 G/T AU WITH 440.6 G/T AG AT ATLANTA
-
Comtech's Former CEOs Nominate Full Slate of Candidates for Comtech Board of Directors
-
Embr Labs Selected as Finalist for the 2024 Digital Health Hub Foundation: Digital Health Awards
-
Elevation Oncology Receives Fast Track Designation from the FDA for EO-3021 for the Treatment of Adult Patients with Advanced or Metastatic Gastric or Gastroesophageal Junction Cancer Expressing Claud
-
VR Resources Closes Acquisition of Empire Properties in Northern Ontario and Commences Copper-Gold Exploration
-
The Distinguished Gentleman’s Drive Celebrates Its Fourth Year on Sunday, September 29, 2024
-
BioAtla and Context Therapeutics Announce Exclusive Worldwide License Agreement to Develop and Commercialize BA3362, a Nectin-4 x CD3 T Cell Engaging Antibody
-
Arrowhead Pharmaceuticals Files for Regulatory Clearance to Initiate Phase 1/2a Study of ARO-INHBE for the Treatment of Obesity
-
The CAST Project fuses K-Culture and commerce at Maison&Objet 2024 Paris
-
Aileron Therapeutics Completes Enrollment in Cohort 2 of the Ongoing Phase 1b Clinical Trial Evaluating LTI-03 in Idiopathic Pulmonary Fibrosis (IPF)
-
Priovant Therapeutics Announces Receipt of Fast Track Designation from FDA for Brepocitinib in Non-Anterior Non-Infectious Uveitis (NIU) & Start of Enrollment of Brepocitinib Phase 3 NIU Program
-
VitalHub Announces Strategic Hire to Accelerate Corporate Growth
-
Bowman Contracted by Illinois Department of Transportation for I-55 Corridor Rehabilitation Project
-
Everbridge 360™ Alert Management, Introduced at GSX 2024, Empowers Organizations to Manage Risk Events with Greater Efficiency and Precision
-
Windstream Announces Refinancing Transactions
-
COSCIENS Biopharma Inc. Provides Updates on Merger Integration, Management Succession Plans and Ongoing Development Programs
-
Stardust Power Welcomes Paramita Das as Chief Strategy Officer and Senior Advisor to Chief Executive
-
Heritage Holding Closes Inaugural Fund with Support from Institutional Capital
-
Nova Leap Health Corp. to Present at the Planet MicroCap Showcase
-
AGF Investments Announces September 2024 Cash Distributions for Certain AGF ETFs and ETF Series
-
Avicanna Announces Medical Cannabis Real World Evidence Study through MyMedi.ca
-
Kenvue Drives Climate Action Strategy Forward
-
Trane Technologies Moves to Reduce Embodied Carbon by 40% by 2030
-
Middlefield Canadian Income PCC - Holding(s) in Company
-
Vitaae® Brings Throat Phlegm Relief to Amazon in Time for Flu Season
-
Allied Universal Named to Forbes List of America's Best Employers by State
-
INEOS QUATTRO FINANCE 2 PLC ANNOUNCES CASH TENDER OFFER FOR ANY AND ALL OF ITS 3 3/8 % SENIOR SECURED NOTES DUE 2026
-
Manufacturing and AI Leader Çağlayan Arkan Joins Sight Machine Board of Directors
-
BofA to Open More Than 165 Financial Centers by End of 2026
-
Fellowship-trained Head and Neck Surgical Oncologist and Microvascular Reconstructive Surgeon Joins Karmanos in Detroit and Flint
-
Fixing of coupon rates - Nykredit Realkredit A/S
-
Dividend Declaration
-
Troilus Refiles Amended and Restated Third Quarter Financial Statements
-
Ipsen’s Kayfanda® (odevixibat) approved in European Union for cholestatic pruritus in Alagille Syndrome, a rare liver disease
-
Ikarao Unveils the Shell S1: A Portable Karaoke Revolution
-
UFC Gym and Alta Global Partnership to Drive $7,000,000 in Potential Gross Annual Revenue Across UFC’s 150+ Global Gym Network
-
Rocket Project at UCLA and Valworx Announce Partnership for Experimental Rocket Project
-
7-Eleven Drops Second Always Open x Ja'Marr Chase Merch Collection
-
Advanced Test Equipment Corporation partners with AE Techron to provide high quality rental options
-
Science & Humans Proudly Welcomes Renowned Healthcare Leader Karim "Matt" Nassar as Chief Growth Officer
-
Mr. Roger Rosmus, Founder & CEO Of Goliath To Present At Noble Capital Markets’ Basic Industries Emerging Growth Virtual Equity Conference, Wednesday September 25th, 2024
